# Livdelzi

NDC: 61958-3301
Generic name: SELADELPAR LYSINE
Labeler / Manufacturer: Gilead Sciences, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240814

FDA application: NDA217899

## Active ingredients

- SELADELPAR LYSINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-3301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-3301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89f79d98-135c-40b2-a585-6996c04e599c